Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.

Published in:

Diabetologia, 2023, v. 66, n. 2, p. 376, doi. 10.1007/s00125-022-05828-w

By:

• Hvid, Henning;
• Brand, Christian L.;
• Hummelshøj, Tina;
• Jensen, Sanne;
• Bouman, Stephan D.;
• Bowler, Andrew;
• Poulsen, Bjarne R.;
• Tiainen, Peter;
• Åkertröm, Thorbjörn;
• Demozay, Damien;
• Hoeg-Jensen, Thomas;
• Ingvorsen, Camilla;
• Pedersen, Thomas Å.;
• McGuire, Jim;
• Egebjerg, Thomas;
• Cappelen, Karen A.;
• Eliasen, Ina P.;
• Hansen, Bo F.;
• Hennen, Stephanie;
• Stidsen, Carsten E.

Publication type:

Article